It is possible that associations may differ by different tumour subtypes, but data on tumour subtypes (e.g., hormone receptor status for breast cancer, aggressiveness of tumour for prostate cancer) were not available in the UK Biobank dataset at the time of these analyses. Here, NR4A1 is linked to prostate cancer.